Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.

McNeil tells NAD it will drop Tylenol ad

Published on .

McNeil Consumer Products Co. has agreed with a decision from the National Advertising Division of the Council of Better Business Bureaus to discontinue an Extra Strength Tylenol spot from Saatchi & Saatchi Advertising's Healthcare Connection, New York. At issue was whether Tylenol appeared to claim superiority in treating "really tough headaches" over American Home Products Corp.'s Advil.

In this article:
Most Popular